Kick off meeting for the ERANET PoC-BoSens Project at the Fraunhofer IZM in Berlin


A great trip to Berlin to kick off a new project, and to meet with our European Partners, led by the Fraunhofer IZM. The Fraunhofer is an inspiring institution - and Berlin shone in the sunshine. We are looking forward to working with the multi-talented partners over the next few years on a highly innovative Point of Care diagnostic system.

MedTech and BioTech are key focus areas for UDA. We will be working across the entire project bringing our systems management, regulatory knowledge and system coherence management to the table.

Opening remarks at MediSens 2018


Medisens 2018 brought together industry, clinicians and researchers at The Royal Marsden Hospital, London. Phil Marsden delivered the opening remarks on the first day and chaired a panel of experts resulting in an interesting and active

debate. The focus on medical imaging in oncology highlighted the need to listen to end users - clinicians are overwhelmed with data, and top requirement is for decision-supporting tools. Scans need to be performed just prior to decision-making

as tumours move and grow. Personalised dose in radiography is key. Good to catch up with industry colleagues and friends too.

Our MD Dr Phil Marsden Appointed Chair of the IOP Medical Physics Group


Phil has been an active member of the IOP for years and has always been fully supportive of the initiatives around encouraging diversity in STEM activities, in reaching out to early stage career researchers and in linking industry with physics research.

He was delighted to be appointed Chair of the Medical Physics group and is determined to bring his energy, ideas and listening skills to make the group even more valuable to all its members.

On that note, we invite you to contact us....

Press Release - UDA secure Innovate UK project with the University of Bristol


Unitive Design and Analysis Ltd are delighted to announce their success in being awarded a grant by Innovate UK, the UK’s innovation agency. Working with the University of Bristol, partners in the UK Quantum Technology Hub and part of the UK National Quantum Technologies Programme, this grant supports the development of a commercial direction for the Quantum Light Source (QLS) - an enormously exciting technology which has profound implications for the future of imaging applications, including medical and biological imaging. QLS represents the successful culmination of research by the University of Bristol who have demonstrated imaging and sensing ‘beyond the shot noise limit’ using quantum technology. Supported by QuantIC and the Quantum Technology Enterprise Centre, Bristol’s research opens a paradigm shift, providing a way to move beyond classical limitations of metrology which until now have been an inevitable part of all imaging and sensing.

Feasibility Study on Brain Imaging Magentoencephalography (MEG) with the University of Nottingham


UDA recently completed a detailed study into the commercial feasibility for a new generation MEG device. Working with the world class research team at the University of Nottingham, Sir Peter Mansfield Imaging Centre, led by Dr Matthew Brookes, we provided an in-depth market analysis with recommendations and a roadmap to take the technology to market. The project was funded by Innovate UK and led by UDA. MEG is a non-invasive brain imaging system which reads magnetic fields produced from the activity of neurons in the brain. Technological breakthroughs by the team in Nottingham promise a new generation system which will be important for research into Mental Health, brain disorders, understanding neurodegenerative diseases, and paediatric epilepsy. Working on this project added significantly to our technical know-how in magnetic imaging and shielding, enhancing our portfolio of medical imaging system expertise.

We wish the extraordinary team at Nottingham the best of luck and future success